At. Michaeltitus et al., BINDING OF TEMOPORFIN TO THE LIPOPROTEIN FRACTIONS OF HUMAN SERUM, British journal of clinical pharmacology, 40(6), 1995, pp. 594-597
The binding of a new photosensitizer, temoporfin, to human serum lipop
roteins was investigated. [C-14]-Temoporfin (0.1-10 mu g ml(-1)) was i
ncubated with human serum for 30 min at room temperature or for 20 h a
t 4 degrees C, prior to stepwise density flotation to separate the lip
oprotein fractions. The distribution of the drug was independent of th
e initial concentration or time and temperature of the incubation. The
proportion of temoporfin in each fraction was: very low density lipop
rotein 6%, low density lipoprotein 22%, lipoprotein(a) 17%, high densi
ty lipoprotein 39% and lipoprotein deficient serum 16%. Autoradiograph
y of agarose gels showed that the drug was associated with the lipopro
tein in the fractions. Fractionation of plasma samples collected from
a patient after an intravenous infusion of temoporfin revealed a bindi
ng profile similar to that obtained in the in vitro study.